{"transactions":[{"id":4640757,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-10-15T01:39:34.000Z","date":"2026-10-12","kind":"sale","planned":false,"acquired":false,"shares":1844,"price":28.05,"value":51724.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a \"sell-to-cover\" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold."}],"balance_after":116701,"source":{"system":"sec-edgar","filing":"0001579629-26-000012","document":"form4-10152026_011030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000157962926000012/form4-10152026_011030.xml","form_type":"4"}},{"id":685165,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-08-17T22:22:36.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":false,"shares":18196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."}],"balance_after":36393,"derivative":{"underlying":"Common Stock","underlying_shares":18196},"source":{"system":"sec-edgar","filing":"0001579629-26-000008","document":"form4-08172026_100832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000008/form4-08172026_100832.xml","form_type":"4"}},{"id":685164,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-08-17T22:22:36.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":4,"price":31.13,"value":124.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."}],"balance_after":118545,"source":{"system":"sec-edgar","filing":"0001579629-26-000008","document":"form4-08172026_100832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000008/form4-08172026_100832.xml","form_type":"4"}},{"id":685163,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-08-17T22:22:36.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":6442,"price":30.35,"value":195514.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $29.99 to $30.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades."}],"balance_after":118549,"source":{"system":"sec-edgar","filing":"0001579629-26-000008","document":"form4-08172026_100832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000008/form4-08172026_100832.xml","form_type":"4"}},{"id":685162,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-08-17T22:22:36.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":2383,"price":29.37,"value":69988.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.97 to $29.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades."}],"balance_after":124991,"source":{"system":"sec-edgar","filing":"0001579629-26-000008","document":"form4-08172026_100832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000008/form4-08172026_100832.xml","form_type":"4"}},{"id":685161,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-08-17T22:22:36.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":true,"shares":18196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":127374,"source":{"system":"sec-edgar","filing":"0001579629-26-000008","document":"form4-08172026_100832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000008/form4-08172026_100832.xml","form_type":"4"}},{"id":711050,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-07-10T23:33:18.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":54589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."}],"balance_after":54589,"derivative":{"underlying":"Common Stock","underlying_shares":54589},"source":{"system":"sec-edgar","filing":"0001579629-26-000004","document":"form4-07102026_110713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000004/form4-07102026_110713.xml","form_type":"4"}},{"id":711049,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal Compliance Officer","other_text":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-07-10T23:33:18.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":54589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents that grant of restricted stock units (\"RSUs\").  The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date."}],"balance_after":109178,"source":{"system":"sec-edgar","filing":"0001579629-26-000004","document":"form4-07102026_110713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000157962926000004/form4-07102026_110713.xml","form_type":"4"}},{"id":739221,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:15:12.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":196299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":196299,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0001193125-26-269468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000119312526269468/ownership.xml","form_type":"4"}},{"id":1111043,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:15:17.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000950170-25-086190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017025086190/ownership.xml","form_type":"4"}},{"id":1480238,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:30:16.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017024073075/ownership.xml","form_type":"4"}},{"id":1533855,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal, Comp & Admin Off"}}],"security":"Employee Stock option (right to buy)","published_at":"2024-04-29T16:15:15.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are subject to a four-year vesting schedule, with 25% vesting one year after the vesting commencement date of October 1, 2023 and the remainder vesting in equal quarterly installments, subject to the Reporting Person's continued service."}],"balance_after":425000,"derivative":{"exercise_price":1.17,"expiration_date":"2033-11-01","underlying":"Class A Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001415889-24-011661","document":"form4-04292024_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000141588924011661/form4-04292024_040401.xml","form_type":"4"}},{"id":1851417,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:00:48.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017023028670/ownership.xml","form_type":"4"}},{"id":2049427,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal and Admin Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:06:29.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":0.7709,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001789769-23-000006","document":"wf-form4_167424877162085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000178976923000006/wf-form4_167424877162085.xml","form_type":"4"}},{"id":2049426,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal and Admin Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:06:29.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":415000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001789769-23-000006","document":"wf-form4_167424877162085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000178976923000006/wf-form4_167424877162085.xml","form_type":"4"}},{"id":2221803,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:15:58.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0000899243-22-024058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000089924322024058/doc4.xml","form_type":"4"}},{"id":2347124,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T00:00:12.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":21461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option shall vest in equal monthly installments over a three year period beginning on June 16, 2021, so that all shares shall have vested on June 16, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":21461,"derivative":{"exercise_price":5.9,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":21461},"source":{"system":"sec-edgar","filing":"0000899243-22-009752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000089924322009752/doc4.xml","form_type":"4"}},{"id":2424002,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-27T16:17:03.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 25, 2022; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":165000,"derivative":{"exercise_price":0.44,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0000899243-22-003439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924322003439/doc4.xml","form_type":"4"}},{"id":2519585,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-09T19:33:27.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0000899243-21-043686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321043686/doc4.xml","form_type":"4"}},{"id":2531811,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-29T18:48:14.000Z","date":"2021-10-27","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person."}],"balance_after":93000,"source":{"system":"sec-edgar","filing":"0000899243-21-042063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321042063/doc4.xml","form_type":"4"}},{"id":2660074,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T21:14:07.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":17724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option shall vest in equal monthly installments over a three year period beginning on June 16, 2021, so that all shares shall have vested on June 16, 2024, subject to the Reporting Person continued service to the Issuer through each vesting date."}],"balance_after":17724,"derivative":{"exercise_price":20.46,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":17724},"source":{"system":"sec-edgar","filing":"0001567619-21-012451","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000156761921012451/doc1.xml","form_type":"4"}},{"id":2899249,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-22T20:36:12.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth (1/4th) of the Option vests one year after January 20, 2021; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":125000,"derivative":{"exercise_price":2.98,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-21-003049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003049/doc4.xml","form_type":"4"}},{"id":2899248,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-22T20:36:12.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on January 3, 2022.  The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0000899243-21-003049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003049/doc4.xml","form_type":"4"}},{"id":2899247,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-22T20:36:12.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest as follows: one-fourth (1/4th) of the shares subject to the Restricted Stock Unit will vest each year after January 20, 2021 until the Restricted Stock Units are fully vested.  The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on each of June 8, 2018, December 10, 2018, June 10, 2019, December 10, 2019, June 10, 2020 and December 10, 2020."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0000899243-21-003049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003049/doc4.xml","form_type":"4"}},{"id":3305318,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-22T18:12:13.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the Company's Severance Benefit Plan."}],"balance_after":110000,"derivative":{"exercise_price":7.41,"expiration_date":"2030-01-17","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-20-001693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924320001693/doc4.xml","form_type":"4"}},{"id":3696426,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-14T16:29:46.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 10, 2019; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the Company's Severance Benefit Plan."}],"balance_after":90000,"derivative":{"exercise_price":4.64,"expiration_date":"2029-01-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-19-001124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319001124/doc4.xml","form_type":"4"}},{"id":3792431,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-11T17:44:43.000Z","date":"2018-10-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after October 9, 2018; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the Company's Severance Benefit Plan."}],"balance_after":25000,"derivative":{"exercise_price":5.61,"expiration_date":"2028-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-026572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318026572/doc4.xml","form_type":"4"}},{"id":4194602,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-03T17:02:16.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after May 23, 2017; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the Company's Severance Benefit Plan."}],"balance_after":75000,"derivative":{"exercise_price":15.75,"expiration_date":"2027-09-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-17-023313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317023313/doc4.xml","form_type":"4"}}]}